Celldex Therapeutics (CLDX) Q2 2016 Earnings

5MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-5.26
-5.11
-4.95
-4.8

Details

Expected EPS
-5.18
Actual EPS
-5.25
Surprise EPS
-0.07
Surprise Percent
+1.35%

Description

Celldex Therapeutics (CLDX) has reported earnings of -5.25 per share for Q2 2016.

0 Comments

Share your thoughts